» Articles » PMID: 34203188

A Primer on the Clinical Aspects of Sarcoidosis for the Basic and Translational Scientist

Overview
Journal J Clin Med
Specialty General Medicine
Date 2021 Jul 2
PMID 34203188
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

The immunopathogenesis of sarcoidosis remains unclear. This failure in understanding has been clinically impactful, as it has impeded the accurate diagnosis, treatment, and prevention of this disease. Unraveling the mechanisms of sarcoidosis will require input from basic and translational scientists. In order to reach this goal, scientists must have a firm grasp of the clinical aspects of the disease, including its diagnostic criteria, the immunologic defects, clinical presentations, response to therapy, risk factors, and clinical course. This manuscript will provide an overview of the clinical aspects of sarcoidosis that are particularly relevant for the basic and translational scientist. The variable phenotypic expression of the disease will be described, which may be integral in identifying immunologic disease mechanisms that may be relevant to subgroups of sarcoidosis patients. Data concerning treatment and risk factors may yield important insights concerning germane immunologic pathways involved in the development of disease. It is hoped that this manuscript will stimulate communication between scientists and clinicians that will eventually lead to improved care of sarcoidosis patients.

Citing Articles

From Karl Wurm and Guy Scadding's staging to F-FDG PET/CT scan phenotyping and far beyond: perspective in the evading history of phenotyping in sarcoidosis.

Papiris S, Kolilekas L, Rivera N, Spanos M, Li G, Gokulnath P Front Med (Lausanne). 2023; 10:1174518.

PMID: 37234239 PMC: 10206027. DOI: 10.3389/fmed.2023.1174518.

References
1.
Vera-Lastra O, Medina G, Cruz-Dominguez M, Ramirez P, Gayosso-Rivera J, Anduaga-Dominguez H . Human adjuvant disease induced by foreign substances: a new model of ASIA (Shoenfeld's syndrome). Lupus. 2012; 21(2):128-35. DOI: 10.1177/0961203311429317. View

2.
Prezant D, Dhala A, Goldstein A, Janus D, Ortiz F, Aldrich T . The incidence, prevalence, and severity of sarcoidosis in New York City firefighters. Chest. 1999; 116(5):1183-93. DOI: 10.1378/chest.116.5.1183. View

3.
Oberstein A, von Zitzewitz H, Schweden F, Muller-Quernheim J . Non invasive evaluation of the inflammatory activity in sarcoidosis with high-resolution computed tomography. Sarcoidosis Vasc Diffuse Lung Dis. 1997; 14(1):65-72. View

4.
Van Dyke M, Martyny J, Mroz M, Silveira L, Strand M, Fingerlin T . Risk of chronic beryllium disease by HLA-DPB1 E69 genotype and beryllium exposure in nuclear workers. Am J Respir Crit Care Med. 2011; 183(12):1680-8. PMC: 3136994. DOI: 10.1164/rccm.201002-0254OC. View

5.
Vatti R, Sharma O . Course of asymptomatic liver involvement in sarcoidosis: role of therapy in selected cases. Sarcoidosis Vasc Diffuse Lung Dis. 1997; 14(1):73-6. View